Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Peginterferon A
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Peginterferon alfa-2a 135micrograms/0.5ml inj pf dispos dev
0802040A0AAAMAM
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2a 135micrograms/0.5ml inj pfs
0802040A0AAAGAG
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2a 180micrograms/0.5ml inj pf dispos dev
0802040A0AAANAN
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2a 180micrograms/0.5ml inj pfs
0802040A0AAAFAF
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2a 90micrograms/0.5ml inj pfs
0802040A0AAAPAP
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 100microgram inj pf dispos dev
0802040A0AAAKAK
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 100microgram inj vials
0802040A0AAABAB
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 120microgram inj pf dispos dev
0802040A0AAAIAI
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 120microgram inj vials
0802040A0AAAEAE
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 150microgram inj pf dispos dev
0802040A0AAAHAH
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 150microgram inj vials
0802040A0AAADAD
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 50microgram inj pf dispos dev
0802040A0AAAJAJ
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 50microgram inj vials
0802040A0AAACAC
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 80microgram inj pf dispos dev
0802040A0AAALAL
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon alfa-2b 80microgram inj vials
0802040A0AAAAAA
|
Peginterferon A | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.